The importance of reaching lipid targets: Statins and the prevention of atherosclerosis

被引:0
|
作者
Schwandt, P [1 ]
机构
[1] Arteriosklerose Pravent Inst, D-81477 Munich, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To help prevent the development of coronary heart disease (CHID), the European and NCEP guidelines have recommended target cholesterol levels for all individuals. Lifestyle changes are advocated for individuals not achieving these targets. Intervention with lipid-modifying agents may be required for patients at high risk of a cardiovascular event and statins are generally recognised as first-line therapy. Unfortunately, large numbers of patients at risk of cardiovascular events are not being treated to the guideline targets. Primary care physicians are in a good position to improve lipid management by assessing risk factors, implementing lipid management strategies, monitoring whether targets are being reached and amending treatment appropriately Furthermore, by educating and motivating patients, primary care physicians may improve compliance with lifestyle changes and medication. These approaches may help more patients to achieve recommended lipid levels and prevent the development of cardiovascular disease.
引用
收藏
页码:396 / 404
页数:9
相关论文
共 50 条
  • [1] NEW TARGETS FOR LIPID-LOWERING AND ATHEROSCLEROSIS PREVENTION
    SIRTORI, CR
    PHARMACOLOGY & THERAPEUTICS, 1995, 67 (03) : 433 - 447
  • [2] The Pleiotropic Effects of Statins in the Prevention of Atherosclerosis
    Kong, Wei
    Zhu, Yi
    CARDIOVASCULAR DRUGS AND THERAPY, 2012, 26 (01) : 5 - 7
  • [3] Clinical importance of some lipid parameters in primary prevention of atherosclerosis in young people
    Faleiro, LL
    Fonseca, A
    Rodrigues, MO
    Martins, MC
    ATHEROSCLEROSIS, 1999, 144 : 191 - 192
  • [4] Potential molecular targets of statins in the prevention of hepatocarcinogenesis
    Ridruejo, Ezequiel
    Romero-Caimi, Giselle
    Obregon, Maria J.
    Kleiman de Pisarev, Diana
    Alvarez, Laura
    ANNALS OF HEPATOLOGY, 2018, 17 (03) : 490 - 500
  • [5] Potential statins molecular targets in hepatocarcinogenesis prevention
    Ridruejo, Ezequiel
    Caimi, Giselle Romero
    de Pisarev, Diana Kleiman
    Obregon, Maria-Jesus
    Alvarez, Laura
    HEPATOLOGY, 2016, 64 : 229A - 229A
  • [6] Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis - guidelines vs. reality
    Bozentowicz-Wikarek, Maria
    Kocelak, Piotr
    Smertka, Mike
    Olszanecka-Glinianowicz, Magdalena
    Chudek, Jerzy
    PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 377 - 385
  • [7] Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis — guidelines vs. reality
    Maria Bożentowicz-Wikarek
    Piotr Kocełak
    Mike Smertka
    Magdalena Olszanecka-Glinianowicz
    Jerzy Chudek
    Pharmacological Reports, 2012, 64 (2) : 377 - 385
  • [8] Non-lipid-lowering effects of statins on atherosclerosis
    Rosenson R.S.
    Current Cardiology Reports, 1999, 1 (3) : 225 - 232
  • [9] New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention
    Anderson, Todd J.
    CANADIAN JOURNAL OF CARDIOLOGY, 2015, 31 (05) : 585 - 587
  • [10] Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities
    Rosenson, RS
    ATHEROSCLEROSIS, 2004, 173 (01) : 1 - 12